Feb 17, 2021 / 11:00PM GMT
Presentation
Feb 17, 2021 / 11:00PM GMT
=====================
Corporate Participants
=====================
* John A. G. Levy
CSL Limited - Senior VP of Corporate Finance & Interim CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul R. Perreault
CSL Limited - MD, CEO & Executive Director
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst
* David Bailey
Macquarie Research - Research Analyst
* David A. Low
JPMorgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc., Research Division - Director & Head of Healthcare in Australia & New Zealand
* Lyanne Harrison
BofA
CSL Ltd
(ASX:CSL)
A$
269.56
+4.06 (+1.53%)
Market Cap: 130.52 Bil
Enterprise Value: 149.52 Bil
PE Ratio: 33.04
PB Ratio: 4.99
GF Score: 93/100 Half Year 2021 CSL Ltd Earnings Presentation Transcript
Feb 17, 2021 / 11:00PM GMT
Release Date Price:
A$281.17
(-1.63%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
